证券记录 · 已归档季度

RARE

Ultragenyx Pharmaceutical Inc. · Healthcare · Biotechnology

15.65 -1.9% 市值 $1.54B 报价延迟（FMP） · 截至 Oct 23 22:08 UTC · 与下方申报数据相互独立

16被追踪持有人

0Δ持有人

17.22M持有股份

$623.52M报告持仓市值

+0新建仓位

−0清仓

Stable 确信度评分 51/100 3 被追踪股份持续上升的季度数 ●●●○○○ 计算方式说明 → 在研究台查询相关说明 →

动量输入（同类管理人）：持有人广度 0.0% · 股份流向 +5.0% · 净新建仓位 0.0% · 公式

所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025

持股变化趋势

季度	持有人	Δ	股份	报告持仓市值	新增	清仓
Q3 2026	2	0	477.97K	$7.18M	+1	−2
Q2 2026	97	-6	59.88M	$1.99B	+8	−14
Q1 2026	106	+4	55.54M	$1.16B	+10	−7
Q4 2025	102	0	62.50M	$1.44B	+1	n/a
Q3 2025	19	-1	45.29M	$1.36B	n/a	−2
Q2 2025	18	-1	33.50M	$1.22B	n/a	−1
Q1 2025	16	0	17.22M	$623.52M	n/a	n/a
Q4 2024	16	+1	16.41M	$690.18M	+1	n/a
Q3 2024	14	+2	15.84M	$879.45M	+2	n/a
Q2 2024	12	n/a	15.75M	$647.24M	n/a	n/a

持有人数量

持有人 · Q1 2025

#	管理人	股份	Δ股份	价值	其权重		持有
1	T. Rowe Price ✦	3.22M	+28.1%	$116.56M	0.0%	▲ Add	4	SEC ↗ ×2
2	State Street Global Advisors ✦ (被动)	2.62M	-3.8%	$94.82M	0.0%	▼ Trim	2	SEC ↗
3	Wellington Management ✦	2.45M	-0.3%	$88.70M	0.0%	▼ Trim	4	SEC ↗ ×6
4	Adage Capital Partners ✦	2.15M	+81.6%	$77.82M	0.1%	▲ Add	4	SEC ↗
5	Geode Capital Management ✦ (被动)	1.65M	+5.4%	$59.64M	0.0%	▲ Add	4	SEC ↗ ×2
6	Norges Bank ✦ (被动)	983.64K	+2.3%	$35.62M	0.0%	▲ Add	4	SEC ↗
7	Point72 Asset Management ✦	976.05K	-17.5%	$35.34M	0.1%	▼ Trim	4	SEC ↗
8	Millennium Management ✦	712.39K	+2.2%	$25.80M	0.0%	▲ Add	4	SEC ↗
9	Two Sigma Investments ✦	633.15K	+3.0%	$22.93M	0.1%	▲ Add	4	SEC ↗
10	D. E. Shaw & Co. ✦	556.42K	+94.5%	$20.15M	0.0%	▲ Add	4	SEC ↗ ×2
11	Marshall Wace ✦	334.08K	-68.2%	$12.10M	0.0%	▼ Trim	4	SEC ↗
12	Renaissance Technologies ✦	299.60K	+17.6%	$10.85M	0.0%	▲ Add	3	SEC ↗
13	Citadel Advisors ✦	256.55K	-10.3%	$9.29M	0.0%	▼ Trim	4	SEC ↗ ×2
14	Fisher Asset Management ✦	207.75K	-21.7%	$7.52M	0.0%	▼ Trim	2	SEC ↗
15	AQR Capital Management ✦	92.05K	-67.2%	$3.31M	0.0%	▼ Trim	4	SEC ↗ ×3
16	Duquesne Family Office ✦	85.44K	0.0%	$3.09M	0.1%	Held	3	SEC ↗